Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Elisa Lazzaroni"'
Autor:
Maria Elena Lunati, Vincenzo Cimino, Davide Bernasconi, Alessandra Gandolfi, Paola Silvia Morpurgo, Camilla Tinari, Elisa Lazzaroni, Laura Baruffaldi, Milena Muratori, Laura Montefusco, Ida Pastore, Antonio Rossi, Ivano Giuseppe Franzetti, Fabrizio Muratori, Roberto Manfrini, Olga Eugenia Disoteo, Rosa Terranova, Paolo Desenzani, Angela Girelli, Renata Ghelardi, Francesca D’Addio, Moufida Ben Nasr, Cesare Berra, Franco Folli, Loredana Bucciarelli, Paolo Fiorina
Publikováno v:
Pharmacological Research, Vol 199, Iss , Pp 107040- (2024)
Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor and semaglutide, a glucagon-like peptide 1 receptor agonist, have both demonstrated efficacy in glycemic control, reducing blood pressure, body weight, risk of renal and heart failure in type
Externí odkaz:
https://doaj.org/article/896fc8acef4049c186f0bd9af04fa581
Autor:
Elisa Lazzaroni, Davide Tosi, Silvia Pontiggia, Riccardo Ermolli, Luca Borghesi, Vittorio Rigamonti, Enrico Frisone, Stefania Piconi
Publikováno v:
Frontiers in Psychology, Vol 13 (2022)
The coronavirus disease 2019 pandemic has represented an individual and collective trauma with an impact on mental health. COVID-19 survivors need to be screened for psychological distress regularly for timely intervention. After March 2020, an outpa
Externí odkaz:
https://doaj.org/article/91ca0a0e3d60406ebd383e43b3410001
Autor:
Elisa Lazzaroni, Maria Elena Lunati, Laura Montefusco, Ida Pastore, Enrica Chebat, Vincenzo Cimino, Paola Silvia Morpurgo, Milena Muratori, Laura Plebani, Andrea Bolla, Antonio Rossi, Luciana Vallone, Alessandra Gandolfi, Camilla Tinari, Francesca D’Addio, Moufida Ben Nasr, Cristian Loretelli, Cristiana Scaranna, Rosalia Bellante, Roberto Manfrini, Fabrizio Muratori, Ivano Franzetti, Emanuela Orsi, Carmine Gazzaruso, Renata Ghelardi, Paolo Desenzani, Stefano Genovese, Angela Girelli, Franco Folli, Cesare Berra, Paolo Fiorina
Publikováno v:
Pharmacological Research, Vol 183, Iss , Pp 106374- (2022)
Dapagliflozin has been demonstrated to improve glycemic control, blood pressure, and body weight in type 2 diabetes mellitus (T2D); indeed, it can also reduce the risk of progression to renal failure, of hospitalization for heart failure and of cardi
Externí odkaz:
https://doaj.org/article/bebdf59a7df04d4580f983cb409b28c8
Autor:
Irene Campi, Guia Vannucchi, Ilaria Muller, Elisa Lazzaroni, Nicola Currò, Martina Dainese, Benedetta Montacchini, Danila Covelli, Claudio Guastella, Lorenzo Pignataro, Laura Fugazzola, Maura Arosio, Mario Salvi
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2022)
BackgroundImmunosuppressive therapy of Graves’ orbitopathy (GO) is indicated during the active phase of disease. Intravenous steroids (IVGC) are effective in about 70% of patients, although unresponsiveness or relapse are observed. In previous stud
Externí odkaz:
https://doaj.org/article/39967c5c314843d390045e80d176a465
Publikováno v:
Frontiers in Psychology, Vol 12 (2021)
The coronavirus disease 2019 (COVID-19) pandemic has represented an individual and collective trauma with an impact on mental health. Restrictive measures such as lockdowns have increased risk factors for the development or triggering of various psyc
Externí odkaz:
https://doaj.org/article/7d8eb8c4c72345da9e44df989d40334a
Autor:
Giulia Lanzolla, Guia Vannucchi, Ilaria Ionni, Irene Campi, Federica Sileo, Elisa Lazzaroni, Michele Marinò
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2020)
Graves' Orbitopathy (GO) is the most frequent extrathyroidal manifestation of Graves' disease (GD). Its ultimate cause remains unclear, but it is commonly considered an autoimmune disorder due to self recognition of autoantigens constitutively expres
Externí odkaz:
https://doaj.org/article/25b5fbb78450418eab7e7b20c1ad1626
Autor:
Giulia Bendotti, Laura Montefusco, Maria Elena Lunati, Vera Usuelli, Ida Pastore, Elisa Lazzaroni, Emma Assi, Andy Joe Seelam, Basset El Essawy, Jun Jang, Cristian Loretelli, Francesca D’Addio, Cesare Berra, Moufida Ben Nasr, GianVincenzo Zuccotti, Paolo Fiorina
Publikováno v:
Pharmacological research. 182
In the last few years, a great interest has emerged in investigating the pleiotropic effects of Glucagon Like Peptide-1 Receptor Agonists (GLP-1RAs). While GLP-1RAs ability to lower plasma glucose and to induce weight loss has allowed them to be appr
Autor:
Claudio Guastella, Davide Dazzi, Marcello Rodari, Nicola Currò, Guia Vannucchi, Elisa Lazzaroni, Giovanna Pepe, Mario Salvi, Danila Covelli, Irene Campi, Arturo Chiti
Publikováno v:
Thyroid. 29:1828-1833
Background: Radioiodine (RAI) is a known risk factor for activation or de novo occurrence of Graves' orbitopathy (GO). Several studies demonstrated that GO can be prevented by glucocorticoids (GCs)...
Autor:
Irene Campi, Guia Vannucchi, Ilaria Muller, Elisa Lazzaroni, Nicola Currò, Martina Dainese, Benedetta Montacchini, Danila Covelli, Claudio Guastella, Lorenzo Pignataro, Laura Fugazzola, Maura Arosio, Mario Salvi
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2022)
BackgroundImmunosuppressive therapy of Graves’ orbitopathy (GO) is indicated during the active phase of disease. Intravenous steroids (IVGC) are effective in about 70% of patients, although unresponsiveness or relapse are observed. In previous stud
Autor:
Laura Montefusco, Ida Pastore, Elio Ippolito, Moufida Ben Nasr, Francesca D'Addio, Andrea Mario Bolla, Elisa Lazzaroni, Paolo Fiorina, Cesare Berra, Antonio Rossi, Maria Elena Lunati, Luciana Vallone, Laura Plebani, Gian Vincenzo Zuccotti, Cristian Loretelli
Publikováno v:
Pharmacological research. 171
Introduction Obesity is frequently a comorbidity of type 2 diabetes. Even modest weight loss can significantly improve glucose homeostasis and lessen cardiometabolic risk factors in patients with type 2 diabetes, but lifestyle‐based weight loss str